Laurent Boissel

Company: NantKwest

Job title: Associate Director, Research & Development

Seminars:

Next Generation of Genetically Engineered NK Cells for Adoptive Immunotherapy 10:40 am

• Treating solid tumors with off-the-shelf engineered aNK cell lines targeting PD-L1 immune checkpoint • Improving activity against the tumor microenvironment through targeting of MDSCs and resistance to hypoxic conditions • Targeting COVID-19 with off-the-shelf CD16-expressing NK cells and convalescent plasmaRead more

day: Day Two